TURNOVER (x1000 NOK)
NET PROFIT (x1000 NOK)
EMPLOYEES
Surgical Science Sweden AB
Closing information (x1000 NOK)
| Closing information | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Turnover |
911,757
|
894,358
|
759,133 |
| Financial expenses |
11,875
|
665
|
18,430 |
| Earnings before taxes |
163,041
|
271,760
|
196,913 |
| EBITDA |
211,246
|
247,955
|
172,337 |
| Total assets |
5,651,174
|
4,763,957
|
4,398,081 |
| Current assets |
1,470,638
|
1,004,109
|
781,675 |
| Current liabilities |
528,769
|
237,999
|
289,362 |
| Equity capital |
4,979,764
|
4,401,838
|
4,007,313 |
| - share capital |
2,631
|
2,584
|
2,403 |
| Employees (average) |
256
|
249
|
227 |
Financial ratios
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Solvency |
88.1%
|
92.4%
|
91.1% |
| Turnover per employee |
3,562
|
3,592
|
3,344 |
| Profit as a percentage of turnover |
17.9%
|
30.4%
|
25.9% |
| Return on assets (ROA) |
3.1%
|
5.7%
|
4.9% |
| Current ratio |
278.1%
|
421.9%
|
270.1% |
| Return on equity (ROE) |
3.3%
|
6.2%
|
4.9% |
| Change turnover |
1,273
|
81,360
|
412,193 |
| Change turnover % |
0%
|
10%
|
119% |
| Chg. No. of employees |
7
|
22
|
106 |
| Chg. No. of employees % |
3%
|
10%
|
88% |
Total value of public sale
| Fiscal year | 2024/12 (consolidated) | 2023/12 (consolidated) | 2022/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.